RIS/PACS vendor Infinitt North America and ultrasound AI firm Us2.ai plan to partner on an AI-powered echocardiography software offering.
The software is intended to streamline cardiac ultrasound measurements needed for the diagnosis, prediction, and management of heart diseases such as pulmonary hypertension and heart failure, according to the two firms. Us2ai's ultrasound reporting software will be incorporated into Infinitt's cardiology suite, a web-based PACS and reporting system for cardiovascular imaging, electrocardiogram management, and nuclear medicine, they noted.
